Sequenom
This article was originally published in The Gray Sheet
Executive Summary
Development stage industrial genomics firm grosses $157 mil. in initial public offering of approximately 6 mil. shares at $26 per share on Feb. 1, including 787,500 overallotment shares. San Diego-based Sequenom outlined plans for the offering late last year (1"The Gray Sheet" Dec. 13, p. 19). The proceeds will be used for expansion of sales, customer support and facilities, as well as continued product development, R&D, debt repayment and other general corporate purposes. The stock trades on the Nasdaq exchange under the symbol "SQNM." Underwriters included Warburg Dillon Read, Robertson Stephens and SG Cowen